Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$431M |
| 2 |
Microsoft
MSFT
|
+$359M |
| 3 |
Amazon
AMZN
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$192M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$248M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$148M |
| 3 |
Procter & Gamble
PG
|
+$112M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$89.3M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$84.7M |
Sector Composition
| 1 | Technology | 22.14% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
ArcBest
ARCB
$1.6B
| $7.26M | ﹤0.01% |
414,472
+3,366
| +0.8% | +$59K |
|
1927
Archrock
AROC
$4.29B
| $7.26M | ﹤0.01% |
1,930,861
-17,074
| -0.9% | -$64.2K |
|
1928
Rocket Pharmaceuticals
RCKT
$341M
| $7.25M | ﹤0.01% |
519,456
+51,151
| +11% | +$714K |
|
1929
Cloudflare
NET
$77.1B
| $7.23M | ﹤0.01% |
308,059
+11,965
| +4% | +$281K |
|
1930
Intellia Therapeutics
NTLA
$1.23B
| $7.23M | ﹤0.01% |
591,041
+42,478
| +8% | +$519K |
|
1931
Krystal Biotech
KRYS
$4.16B
| $7.22M | ﹤0.01% |
166,895
+20,112
| +14% | +$870K |
|
1932
Herc Holdings
HRI
$4.2B
| $7.2M | ﹤0.01% |
351,762
+17,902
| +5% | +$366K |
|
|
VSTO
1933
DELISTED
Vista Outdoor Inc.
VSTO
| $7.19M | ﹤0.01% |
816,601
+48,719
| +6% | +$429K |
|
1934
Calix
CALX
$4.01B
| $7.18M | ﹤0.01% |
1,014,726
+56,991
| +6% | +$403K |
|
|
MSGN
1935
DELISTED
MSG Networks Inc.
MSGN
| $7.18M | ﹤0.01% |
704,151
+93,527
| +15% | +$954K |
|
|
SP
1936
DELISTED
SP Plus Corporation
SP
| $7.16M | ﹤0.01% |
344,867
+14,454
| +4% | +$300K |
|
|
HA
1937
DELISTED
Hawaiian Holdings, Inc.
HA
| $7.15M | ﹤0.01% |
684,426
+37,262
| +6% | +$389K |
|
|
SINA
1938
DELISTED
Sina Corp
SINA
| $7.14M | ﹤0.01% |
225,496
-23,469
| -9% | -$743K |
|
1939
Acco Brands
ACCO
$361M
| $7.14M | ﹤0.01% |
1,414,001
+107,070
| +8% | +$541K |
|
1940
Veeco
VECO
$1.52B
| $7.13M | ﹤0.01% |
745,305
+30,087
| +4% | +$288K |
|
|
EGRX
1941
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.11M | ﹤0.01% |
154,469
-6,648
| -4% | -$306K |
|
1942
Infosys
INFY
$70.3B
| $7.1M | ﹤0.01% |
867,268
+103,896
| +14% | +$850K |
|
|
TBI
1943
Trueblue
TBI
$179M
| $7.05M | ﹤0.01% |
552,796
+34,512
| +7% | +$440K |
|
1944
GSK
GSK
$82.2B
| $7.05M | ﹤0.01% |
148,765
-56,437
| -28% | -$2.67M |
|
1945
Atara Biotherapeutics
ATRA
$85.1M
| $7.04M | ﹤0.01% |
33,109
+3,771
| +13% | +$802K |
|
|
CLR
1946
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $7.02M | ﹤0.01% |
920,354
+36,838
| +4% | +$281K |
|
1947
Range Resources
RRC
$8.41B
| $6.97M | ﹤0.01% |
3,057,159
+755,553
| +33% | +$1.72M |
|
|
PETQ
1948
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $6.95M | ﹤0.01% |
299,220
+49,332
| +20% | +$1.15M |
|
|
EIDX
1949
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $6.93M | ﹤0.01% |
141,543
+19,238
| +16% | +$942K |
|
1950
Ennis
EBF
$463M
| $6.92M | ﹤0.01% |
368,533
+23,721
| +7% | +$445K |
|